Akso Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Akso Health Group
AHG Stock  USD 1.47  0.05  3.52%   
Akso Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Akso Health's valuation are provided below:
Gross Profit
-281.5 K
Market Capitalization
807.3 M
Enterprise Value Revenue
40.175
Revenue
14.8 M
Earnings Share
(0.48)
There are over one hundred nineteen available fundamental signals for Akso Health Group, which can be analyzed over time and compared to other ratios. Active traders should verify all of Akso Health Group prevailing fundamental drivers against the trend between 2010 and 2026 to make sure the company can sustain itself down the road. The Akso Health's current Enterprise Value is estimated to increase to about 246.3 M, while Market Cap is projected to decrease to roughly 294 M.

Akso Health Total Revenue

18.43 Million

Check Akso Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Akso Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Selling General Administrative of 4 M or Selling And Marketing Expenses of 144 K, as well as many indicators such as Price To Sales Ratio of 30.39, Dividend Yield of 0.088 or PTB Ratio of 1.85. Akso financial statements analysis is a perfect complement when working with Akso Health Valuation or Volatility modules.
  
Build AI portfolio with Akso Stock
Check out the analysis of Akso Health Correlation against competitors.

Akso Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets259.6 M247.2 M86.6 M
Slightly volatile
Other Current Liabilities3.8 M4.1 M7.5 M
Pretty Stable
Total Current Liabilities16.2 M15.9 M12.4 M
Slightly volatile
Total Stockholder Equity240.4 M229 M71.4 M
Slightly volatile
Cash212.8 M202.7 M55.9 M
Slightly volatile
Non Current Assets Total10.5 M16.9 M11.5 M
Very volatile
Cash And Short Term Investments212.8 M202.7 M55.9 M
Slightly volatile
Common Stock Shares Outstanding344.3 M327.9 M62.8 M
Slightly volatile
Liabilities And Stockholders Equity259.6 M247.2 M86.6 M
Slightly volatile
Other Current Assets8.8 M7.8 M6.4 M
Slightly volatile
Other Stockholder Equity485 M461.9 M115.4 M
Slightly volatile
Total Liabilities20.4 M18.2 M15.2 M
Slightly volatile
Total Current Assets236.8 M225.5 M74.2 M
Slightly volatile
Common Stock200.1 K190.5 K37.8 K
Slightly volatile
Net Receivables24.1 M14.8 M15.5 M
Slightly volatile
Net Tangible Assets7.5 M7.9 M80.4 M
Slightly volatile
Net Invested Capital240.4 M229 M128.8 M
Pretty Stable
Net Working Capital220.1 M209.7 M118.4 M
Very volatile
Intangible Assets9.5 M9.1 M4.5 M
Slightly volatile
Property Plant Equipment47.4 K49.9 K502.3 K
Slightly volatile
Short and Long Term Debt Total69.9 K73.6 K13.7 M
Slightly volatile
Other Liabilities152 K171 K186.6 K
Slightly volatile
Current Deferred Revenue12.3 M11.7 M2.1 M
Slightly volatile
Long Term Debt16 M18 M19.6 M
Slightly volatile
Capital Stock200.1 K190.5 K39.3 K
Slightly volatile
Short Term Debt34.2 K36.1 K2.3 M
Pretty Stable
Short and Long Term Debt8 M9 M9.8 M
Slightly volatile

Akso Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative4 M4.2 M6.2 M
Slightly volatile
Selling And Marketing Expenses144 K151.6 K4.2 M
Pretty Stable
Total Revenue18.4 M13.3 M17.9 M
Very volatile
Other Operating Expenses218.7 M208.2 M52.1 M
Slightly volatile
Research Development3.213.383.5 M
Pretty Stable
Cost Of Revenue18.2 M17.3 M6.3 M
Slightly volatile
Total Operating Expenses200.5 M190.9 M46 M
Slightly volatile
Interest Income472.1 K531.1 K579.7 K
Slightly volatile

Akso Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow212.8 M202.7 M56.3 M
Slightly volatile
Begin Period Cash Flow104.1 M99.1 M33.5 M
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio30.3926.1851.9342
Slightly volatile
Dividend Yield0.0880.09950.1086
Slightly volatile
PTB Ratio1.851.9458.0944
Slightly volatile
Days Sales Outstanding272287682
Pretty Stable
Book Value Per Share0.760.84.8319
Very volatile
Stock Based Compensation To Revenue0.07130.07510.1416
Very volatile
Capex To Depreciation0.07850.08264.0187
Slightly volatile
PB Ratio1.851.9458.0944
Slightly volatile
Inventory Turnover74.8171.2414.8568
Slightly volatile
Days Of Inventory On Hand5.045.3378
Slightly volatile
Sales General And Administrative To Revenue0.210.220.8098
Slightly volatile
Average Inventory208.4 K219.3 K3.7 M
Slightly volatile
Research And Ddevelopement To Revenue0.07670.08070.1893
Slightly volatile
Capex To Revenue0.00890.00940.0365
Pretty Stable
Cash Per Share0.680.713.219
Very volatile
Payout Ratio2.823.183.4704
Slightly volatile
Intangibles To Total Assets0.08230.07840.0463
Slightly volatile
Current Ratio13.4212.786.4005
Slightly volatile
Tangible Book Value Per Share0.690.734.8161
Very volatile
Receivables Turnover1.251.324.6069
Slightly volatile
Shareholders Equity Per Share0.760.84.8308
Very volatile
Debt To Equity4.0E-45.0E-40.1433
Slightly volatile
Capex Per Share6.0E-46.0E-40.0351
Slightly volatile
Average Receivables5 M5.3 M10 M
Pretty Stable
Revenue Per Share0.05660.05962.1356
Pretty Stable
Interest Debt Per Share3.0E-43.0E-42.1924
Slightly volatile
Debt To Assets4.0E-44.0E-40.095
Slightly volatile
Graham Number8.46.46.4682
Slightly volatile
Short Term Coverage Ratios0.810.910.9887
Slightly volatile
Operating Cycle353372709
Pretty Stable
Price Book Value Ratio1.851.9458.0944
Slightly volatile
Dividend Payout Ratio2.823.183.4704
Slightly volatile
Ebt Per Ebit1.031.150.9766
Very volatile
Company Equity Multiplier1.50.971.8775
Pretty Stable
Long Term Debt To Capitalization0.180.260.2018
Slightly volatile
Total Debt To Capitalization4.0E-45.0E-40.1117
Slightly volatile
Debt Equity Ratio4.0E-45.0E-40.1433
Slightly volatile
Quick Ratio13.412.776.3772
Slightly volatile
Cash Ratio12.0611.484.4948
Slightly volatile
Cash Conversion Cycle353372709
Pretty Stable
Days Of Inventory Outstanding5.045.3378
Slightly volatile
Days Of Sales Outstanding272287682
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.820.780.957
Pretty Stable
Price To Book Ratio1.851.9458.0944
Slightly volatile
Fixed Asset Turnover12211666.1816
Slightly volatile
Debt Ratio4.0E-44.0E-40.095
Slightly volatile
Price Sales Ratio30.3926.1851.9342
Slightly volatile
Asset Turnover0.07510.07910.3693
Slightly volatile
Price Fair Value1.851.9458.0944
Slightly volatile

Akso Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap294 M386.9 M355.7 M
Slightly volatile

Akso Fundamental Market Drivers

Akso Upcoming Events

13th of October 2023
Upcoming Quarterly Report
View
30th of June 2023
Next Fiscal Quarter End
View

About Akso Health Financial Statements

Akso Health stakeholders use historical fundamental indicators, such as Akso Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Akso Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Akso Health's assets and liabilities are reflected in the revenues and expenses on Akso Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Akso Health Group. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue11.7 M12.3 M
Total Revenue13.3 M18.4 M
Cost Of Revenue17.3 M18.2 M
Stock Based Compensation To Revenue 0.08  0.07 
Sales General And Administrative To Revenue 0.22  0.21 
Research And Ddevelopement To Revenue 0.08  0.08 
Capex To Revenue 0.01  0.01 
Revenue Per Share 0.06  0.06 
Ebit Per Revenue(12.94)(12.29)

Currently Active Assets on Macroaxis

MSFTMicrosoft
DDDupont De Nemours
WDWalker Dunlop
GOOGAlphabet Inc Class C
CRMSalesforce
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports:
How To Invest In Akso
Details
Is Akso Stock a good investment?
Details
What is Akso Health's Net Worth?
Details
Largest Health Care Equipment & Supplies Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Akso Health Correlation against competitors.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Akso have expansion opportunities? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Akso Health demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(0.48)
Revenue Per Share
0.052
Quarterly Revenue Growth
4.158
Return On Assets
(0.01)
Return On Equity
(0.80)
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
Understanding that Akso Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Akso Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Akso Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY